Today: 5 April 2026
Subscribe
Browse Category

Earnings Reports 5 February 2026

Tower Semiconductor stock jumps on Nvidia 1.6T silicon photonics tie-up as traders eye Feb. 11 results

Tower Semiconductor stock jumps on Nvidia 1.6T silicon photonics tie-up as traders eye Feb. 11 results

Tower Semiconductor shares rose 6.6% to $129.29 Thursday after announcing a partnership with Nvidia to develop 1.6-terabit optical modules for data centers. The company touted its silicon photonics platform for boosting AI networking speeds. No financial terms or production timelines were disclosed. Investors await Tower’s Feb. 11 earnings for updates on demand and project progress.
5 February 2026
·····
Why Lam Research (LRCX) stock is bouncing after a bruising 9% drop

Why Lam Research (LRCX) stock is bouncing after a bruising 9% drop

Lam Research shares rose 1.6% to $213.12 by midday Thursday after rebounding from an 8.83% drop the previous day, with trading volume spiking to 19.6 million shares. The company named Cadence CEO Anirudh Devgan to its board and announced Sesha Varadarajan as incoming COO. Chip equipment stocks remained volatile amid uncertainty in the AI sector. Traders await the delayed U.S. January jobs report on Feb. 11.
5 February 2026
··
Roblox stock price steadies as new “4D creation” AI push meets earnings test after the bell

Roblox stock price steadies as new “4D creation” AI push meets earnings test after the bell

Roblox shares edged up 0.1% to $63.16 midday Thursday after launching a new AI-powered creation tool. The company will report fourth-quarter earnings after the bell, with forecasts calling for a 47-cent loss per share on $2.07 billion in revenue. Investors are focused on user engagement, spending, and the impact of new safety measures.
5 February 2026
···
Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna stock jumps as earnings beat meets soft 2026 outlook and FTC insulin settlement

Cigna shares rose 3.2% to $280.46 after posting Q4 adjusted earnings of $8.08 per share, above forecasts, though its 2026 outlook missed estimates. Express Scripts agreed to a 10-year FTC settlement on insulin pricing, expected to cut patient costs by up to $7 billion. Evernorth pharmacy revenue jumped 20% to $36.3 billion. Cigna’s board raised its quarterly dividend to $1.56 per share.
5 February 2026
···
Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent shares fell 3.9% to $202.69 in late morning New York trading Thursday after posting fiscal Q2 revenue of $1.69 billion, up 17% from last year. The company expects Q3 revenue between $1.70 billion and $1.84 billion, with non-GAAP EPS forecast at $1.28 to $1.48. Trading volume topped 5.8 million shares after a volatile open. Shares were briefly halted for volatility at 09:38 a.m. ET.
5 February 2026
··
Tapestry stock jumps after Coach Tabby handbag demand drives earnings beat, outlook hike

Tapestry stock jumps after Coach Tabby handbag demand drives earnings beat, outlook hike

Tapestry Inc shares rose 3.8% to $134.87 after reporting a 14% jump in quarterly sales to $2.50 billion and raising its full-year outlook. Coach revenue surged 25% while Kate Spade sales fell 14%. The company now expects fiscal 2026 revenue above $7.75 billion and plans $1.5 billion in shareholder returns. The stock earlier jumped nearly 9% before paring gains.
5 February 2026
··
Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir shares fell 6.8% to $130.11 Thursday morning, extending a two-day slide that erased most of Tuesday’s rally. The drop follows a 12% plunge Wednesday amid concerns over AI-driven valuations and sector volatility. Director Alexander D. Moore disclosed selling 20,000 shares last week. Investors await U.S. economic data next week that could shift rate expectations for growth stocks.
5 February 2026
···
Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.
5 February 2026
····
Symbotic stock drops in premarket after Q1 outlook — $22.3B backlog and margins in focus

Symbotic stock drops in premarket after Q1 outlook — $22.3B backlog and margins in focus

Symbotic shares fell about 5% to $53.48 in premarket trading after posting $630 million in quarterly revenue and forecasting $650 million to $670 million for the next quarter. The company reported a $13 million profit, up from a $17 million loss a year ago. Needham raised its price target to $75. Investors remain cautious amid project timing swings and concentrated client exposure.
5 February 2026
··
Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific stock tries to steady after an 18% earnings drop put EP business on edge

Boston Scientific shares rose about 1% in Thursday premarket trading after plunging 17.6% Wednesday on weak electrophysiology sales and a softer 2026 outlook. Q4 electrophysiology revenue missed analyst estimates, and U.S. Watchman sales fell short. The stock traded near $76.30 after closing at $75.50. CEO Michael Mahoney said Q4 results beat internal targets but warned of challenges in the first quarter.
5 February 2026
··
Suzlon Energy Q3 results: Profit up 15%, revenue jumps 42% — but shares still slide

Suzlon Energy Q3 results: Profit up 15%, revenue jumps 42% — but shares still slide

Suzlon Energy shares fell nearly 6% to 47.76 rupees on Thursday after Q3 net profit rose 15% year-on-year to 4.45 billion rupees. Revenue from operations jumped 42% to 42.28 billion rupees. The company delivered a record 617 MW in the quarter, with an order book of 6.4 GW as of December 31. Sequential profit dropped 65% from the previous quarter, partly due to a prior deferred tax gain.
5 February 2026
···
AppLovin stock tumbles on CloudX AI threat talk as traders brace for earnings

AppLovin stock tumbles on CloudX AI threat talk as traders brace for earnings

AppLovin shares fell 16.1% Wednesday to $387.34, following a 4.4% drop Tuesday, as trading volume topped 15 million shares. The declines came amid a broader selloff in software stocks and new competition from CloudX, a startup led by a former MoPub co-founder. AppLovin will report fourth-quarter and full-year results on Feb. 11 after the market closes.
5 February 2026
····
Saab stock drops after earnings beat and raised growth target as investors weigh what’s next

Saab stock drops after earnings beat and raised growth target as investors weigh what’s next

Saab shares fell 3.1% Thursday despite reporting record Q4 order bookings of SEK 100.1 billion and raising its 2023–27 sales growth target to 22% annually. Operating profit jumped 67% to SEK 3.26 billion, and the board proposed a higher dividend. Investors focused on execution risks and the lack of detailed 2026 guidance. The stock has tripled over the past year amid rising European defence budgets.
5 February 2026
··
1 … 32 33 34 35 36 … 229

Stock Market Today

  • 3 Tech Stocks Down Over 25% Poised for 2026 Rebound: Microsoft, Meta, Broadcom
    April 5, 2026, 4:32 PM EDT. The tech sector is sharply down in 2026, with Microsoft, Meta Platforms, and Broadcom each off more than 25% from their all-time highs. Microsoft, trading near $373 with a 30% drop, leads in artificial intelligence (AI) platform services, presenting a strong buy opportunity amid no looming economic crash. Meta, down past 25%, invests heavily in AI at $115-$135 billion this year, yet posted a 24% revenue rise in Q4, underscoring its advertising strength despite market skepticism. Meta's valuation at 19 times forward earnings offers notable value. Broadcom, also significantly discounted, rounds out the trio as prime rebound candidates before the anticipated tech sector upswing.
Go toTop